Recruiting PHASE2 Breast Cancer

New treatment option for Breast Cancer

Official title Microbiome and Association With Implant Infections

ClinicalTrials.gov ID: NCT05020574

What this study is testing

What is Cephalexin?

Cephalexin is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for breast cancer.

Also referred to as Keflex.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The most common tissue expander-related infections are from Staphylococcus and Pseudomonas species. In addition, from breast tissue microbiome studies, Staphylococcus and Pseudomonas show variable abundance across samples.
  • Phase 2: a mid-size study of how well it works
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older, women only

You may be able to join if

  • Patients must have histologically confirmed breast malignancy OR genetic predisposition to breast cancer.
  • Age \>= 18 years
  • Scheduled to undergo mastectomy with the immediate placement of tissue expanders or implant placement
  • Ability to understand a written informed consent document, and the willingness to sign it
  • At least 4 weeks post-completion of chemotherapy or radiation therapy.

You likely can't join if

  • Any significant medical condition or laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the...
  • Pregnant or breastfeeding
  • Patients who have taken antibiotics within 90 days of the consent date
  • Patients who have taken probiotics within 90 days of the consent date
  • Patients who have a documented or reported allergic reaction to the outlined antibiotics to be used in this study
  • Male patients

The study team makes the final eligibility decision.

Where it's taking place

  • San Francisco, California, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include San Francisco, California, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.